{"seed": 4527214, "spark": "Title: N12 - The US promotes the removal of the patent from the corona vaccines - mako\nDescription: The Biden administration has expressed complete support for the proposal to remove intellectual property protection from the corona vaccines \u2022 India and South Africa have been promoting the idea for months, but have encountered opposition from Trump himself, the European Union and the United Kingdom\nOriginal Language: Hebrew", "motivation": {"introduction": "In response to the US government's support for waiving patent protections on corona vaccines, as highlighted by the recent article in N12, a fascinating exploration into the potential global impact of this decision could be conducted. By examining vaccine production and distribution data across different countries, especially focusing on those previously unable to access patented vaccines, this investigation would reveal how such a policy shift might affect global health outcomes and vaccine availability. The analysis would compare the rate of vaccine distribution and COVID-19 case trends before and after the policy announcement, providing a clear picture of its real-world implications.", "title": "GlobalImpact_PatentWaiver_CoronaVaccines"}, "nodes": [{"name": "Economic Status of Countries", "description": "Economic status of various countries, influencing their healthcare capacities", "type": "confounder", "observed": true, "values": ["Low Economic Status", "High Economic Status"], "parents": []}, {"name": "Patent Waiver Implementation", "description": "Implementation of the waiver for patents on COVID-19 vaccines", "type": "treatment", "observed": true, "values": ["Not Implemented", "Implemented"], "parents": ["Economic Status of Countries"]}, {"name": "Pharmaceutical Industry Influence", "description": "Influence of the pharmaceutical industry on policy and distribution", "type": "confounder", "observed": true, "values": ["Low Influence", "High Influence"], "parents": []}, {"name": "Global Health Policy Support", "description": "Support for health policies aiding global vaccine distribution", "type": "treatment", "observed": true, "values": ["Not Supported", "Supported"], "parents": ["Pharmaceutical Industry Influence"]}, {"name": "Vaccine Production Capacity", "description": "Capacity to produce COVID-19 vaccines in different countries", "type": "mediator", "observed": true, "values": ["Low Capacity", "High Capacity"], "parents": ["Economic Status of Countries", "Pharmaceutical Industry Influence"]}, {"name": "International Vaccine Distribution", "description": "Distribution of COVID-19 vaccines internationally", "type": "mediator", "observed": true, "values": ["Inefficient Distribution", "Efficient Distribution"], "parents": ["Global Health Policy Support"]}, {"name": "Global Vaccine Availability", "description": "Availability of COVID-19 vaccines globally", "type": "outcome", "observed": true, "values": ["Not Available", "Available"], "parents": ["Patent Waiver Implementation", "International Vaccine Distribution", "Vaccine Production Capacity"]}, {"name": "Public Health Awareness", "description": "Level of public health awareness among the global population", "type": "collider", "observed": true, "values": ["Low Awareness", "High Awareness"], "parents": ["Global Vaccine Availability", "Global Health Policy Support"]}], "stats": {"1": [0.3, 0.4], "2": [0.6, 0.7], "3": [0.2, 0.3], "4": [0.5, 0.6], "5": [0.4, 0.5], "6": [0.3, 0.4], "7": [0.2, 0.3], "8": [0.4, 0.5], "9": [0.6, 0.7], "10": [0.7, 0.8], "11": [0.3, 0.4], "12": [0.6, 0.7], "13": [0.1, 0.2], "14": [0.3, 0.4], "15": [0.4, 0.5], "16": [0.6, 0.7], "17": [0.2, 0.3], "18": [0.5, 0.6], "19": [0.7, 0.8], "20": [0.9, 1.0], "21": [0.2, 0.3], "22": [0.3, 0.4], "23": [0.4, 0.5], "24": [0.6, 0.7]}, "structure": [{"sentence": "The economic status of different countries plays a pivotal role in shaping their healthcare capacities, which in turn influences whether they implement the waiver for patents on COVID-19 vaccines.", "involved": ["Economic Status of Countries", "Patent Waiver Implementation"]}, {"sentence": "Interestingly, the influence of the pharmaceutical industry not only affects the support for health policies aiding vaccine distribution but also indirectly impacts the production capacity of COVID-19 vaccines in various countries.", "involved": ["Pharmaceutical Industry Influence", "Global Health Policy Support", "Vaccine Production Capacity"]}, {"sentence": "The availability of COVID-19 vaccines globally is determined by a combination of factors including the implementation of patent waivers, the efficiency of international vaccine distribution, and the vaccine production capacity of different countries.", "involved": ["Global Vaccine Availability", "Patent Waiver Implementation", "International Vaccine Distribution", "Vaccine Production Capacity"]}, {"sentence": "Support for global health policies not only directly affects the international distribution of vaccines but also plays a part in raising public health awareness among the global population.", "involved": ["Global Health Policy Support", "International Vaccine Distribution", "Public Health Awareness"]}, {"sentence": "Public health awareness is shaped by both the availability of vaccines globally and the general support for health policies, highlighting the interconnected nature of public perception and policy outcomes.", "involved": ["Public Health Awareness", "Global Vaccine Availability", "Global Health Policy Support"]}, {"sentence": "The capacity to produce vaccines within countries is influenced by their economic status, reflecting how financial resources can be a crucial factor in responding to global health crises.", "involved": ["Vaccine Production Capacity", "Economic Status of Countries"]}, {"sentence": "A country's decision to waive vaccine patents is not only a matter of health policy but is also intertwined with its economic landscape, underlining the complex interplay between economic and health factors.", "involved": ["Patent Waiver Implementation", "Economic Status of Countries"]}], "verbs": {"Economic Status of Countries": {"descriptor": ["the economic standing of nations", "countries' financial health"], "subject": "countries", "predicate0": ["struggle economically", "have a weaker economy"], "predicate1": ["flourish economically", "boast strong economies"], "pronoun": "they", "nounclause0": ["a country is economically struggling", "a nation has a weaker economy"], "nounclause1": ["a country is economically flourishing", "a nation has a strong economy"], "preposition": ["in", "among"], "domain": "nations", "subclause0": ["a nation's economy is underdeveloped", "economic development is limited"], "subclause1": ["a nation's economy is thriving", "economic development is robust"], "condition0": ["in countries with weaker economies", "when a nation struggles financially"], "condition1": ["in countries with strong economies", "when a nation is economically stable"], "action0": ["a country's economic status declines", "nations face financial downturns"], "action1": ["a country's economic status improves", "nations experience economic growth"]}, "Patent Waiver Implementation": {"descriptor": ["the implementation of patent waivers", "waiving vaccine patents"], "subject": "governments", "predicate0": ["do not implement patent waivers", "reject the waiver for vaccine patents"], "predicate1": ["implement patent waivers", "approve the waiver for vaccine patents"], "pronoun": "they", "nounclause0": ["patent waivers are not implemented", "vaccine patents are upheld"], "nounclause1": ["patent waivers are implemented", "vaccine patents are waived"], "preposition": ["with", "in"], "domain": "countries", "subclause0": ["the implementation of patent waivers is rejected", "vaccine patents remain intact"], "subclause1": ["the implementation of patent waivers is approved", "vaccine patents are waived"], "condition0": ["if patent waivers are not implemented", "when vaccine patents are upheld"], "condition1": ["if patent waivers are implemented", "when vaccine patents are waived"], "action0": ["patent waivers are rejected", "vaccine patents are maintained"], "action1": ["patent waivers are approved", "vaccine patents are waived"]}, "Pharmaceutical Industry Influence": {"descriptor": ["the influence of the pharmaceutical industry", "pharmaceutical companies' clout"], "subject": "the pharmaceutical industry", "predicate0": ["has minimal sway", "exerts little influence"], "predicate1": ["has significant sway", "exerts strong influence"], "pronoun": "it", "nounclause0": ["the pharmaceutical industry holds minimal sway", "pharmaceutical companies have little influence"], "nounclause1": ["the pharmaceutical industry holds significant sway", "pharmaceutical companies have strong influence"], "preposition": ["within", "among"], "domain": "policies", "subclause0": ["the industry's  influence is minimal", "there's little sway from pharmaceutical companies"], "subclause1": ["the industry's influence is significant", "there's strong sway from pharmaceutical companies"], "condition0": ["when the pharmaceutical industry has minimal influence", "if pharmaceutical companies have little sway"], "condition1": ["when the pharmaceutical industry has significant influence", "if pharmaceutical companies wield strong influence"], "action0": ["the pharmaceutical industry's influence wanes", "pharmaceutical companies lose their sway"], "action1": ["the pharmaceutical industry's influence grows", "pharmaceutical companies gain more sway"]}, "Global Health Policy Support": {"descriptor": ["support for global health policies", "backing of worldwide health initiatives"], "subject": "the global community", "predicate0": ["does not support health policies", "is hesitant about global health initiatives"], "predicate1": ["supports health policies", "is proactive about global health initiatives"], "pronoun": "it", "nounclause0": ["there is no support for health policies", "global health initiatives lack backing"], "nounclause1": ["there is support for health policies", "global health initiatives receive backing"], "preposition": ["among", "within"], "domain": "nations", "subclause0": ["global health policies are not supported", "health initiatives fail to gain momentum"], "subclause1": ["global health policies are widely supported", "health initiatives gain strong momentum"], "condition0": ["without support for health policies", "if global health initiatives are not backed"], "condition1": ["with support for health policies", "if global health initiatives are backed"], "action0": ["health policies lack support", "global health initiatives are not backed"], "action1": ["health policies are supported", "global health initiatives are backed"]}, "Vaccine Production Capacity": {"descriptor": ["vaccine production capacity", "the ability to manufacture vaccines"], "subject": "countries", "predicate0": ["have low vaccine production capacity", "struggle to manufacture vaccines"], "predicate1": ["have high vaccine production capacity", "excel in manufacturing vaccines"], "pronoun": "they", "nounclause0": ["vaccine production is limited", "there is a struggle in vaccine manufacturing"], "nounclause1": ["vaccine production is robust", "there is efficiency in vaccine manufacturing"], "preposition": ["in", "among"], "domain": "nations", "subclause0": ["there's a limitation in producing vaccines", "vaccine manufacturing is not sufficient"], "subclause1": ["there's a robust vaccine production", "vaccine manufacturing is efficient"], "condition0": ["if vaccine production is low", "when countries struggle with vaccine manufacturing"], "condition1": ["if vaccine production is high", "when countries excel in vaccine manufacturing"], "action0": ["vaccine production capacity decreases", "vaccine manufacturing abilities decline"], "action1": ["vaccine production capacity increases", "vaccine manufacturing abilities improve"]}, "International Vaccine Distribution": {"descriptor": ["international vaccine distribution", "the global dissemination of vaccines"], "subject": "vaccines", "predicate0": ["are distributed inefficiently", "face distribution challenges globally"], "predicate1": ["are distributed efficiently", "are widely accessible globally"], "pronoun": "they", "nounclause0": ["there's inefficient distribution of vaccines", "vaccines face global distribution challenges"], "nounclause1": ["there's efficient distribution of vaccines", "vaccines are widely accessible globally"], "preposition": ["in", "throughout"], "domain": "the world", "subclause0": ["vaccine distribution faces hurdles", "global vaccine access is limited"], "subclause1": ["vaccine distribution is smooth", "global vaccine access is widespread"], "condition0": ["when vaccine distribution is inefficient", "if global vaccine access is limited"], "condition1": ["when vaccine distribution is efficient", "if global vaccine access is widespread"], "action0": ["vaccine distribution faces hurdles", "global vaccine access becomes limited"], "action1": ["vaccine distribution is optimized", "global vaccine access improves"]}, "Global Vaccine Availability": {"descriptor": ["global vaccine availability", "the worldwide access to vaccines"], "subject": "COVID-19 vaccines", "predicate0": ["are not available globally", "lack worldwide access"], "predicate1": ["are available globally", "are accessible worldwide"], "pronoun": "they", "nounclause0": ["there's a lack of global vaccine availability", "vaccines are not accessible worldwide"], "nounclause1": ["there's global vaccine availability", "vaccines are accessible worldwide"], "preposition": ["across", "throughout"], "domain": "the world", "subclause0": ["vaccines are not available in many regions", "worldwide vaccine access is limited"], "subclause1": ["vaccines are available in most regions", "worldwide vaccine access is widespread"], "condition0": ["if vaccines are not available globally", "when worldwide access to vaccines is limited"], "condition1": ["if vaccines are available globally", "when worldwide access to vaccines is widespread"], "action0": ["global vaccine availability decreases", "worldwide access to vaccines becomes limited"], "action1": ["global vaccine availability increases", "worldwide access to vaccines expands"]}, "Public Health Awareness": {"descriptor": ["public health awareness", "awareness of health issues among the populace"], "subject": "the public", "predicate0": ["has low awareness of health issues", "is less informed about health matters"], "predicate1": ["has high awareness of health issues", "is well-informed about health matters"], "pronoun": "they", "nounclause0": ["there's a low level of health awareness", "people are less informed about health matters"], "nounclause1": ["there's a high level of health awareness", "people are well-informed about health matters"], "preposition": ["among", "in"], "domain": "populations", "subclause0": ["awareness of health issues is lacking", "people are not well-informed about health"], "subclause1": ["awareness of health issues is high", "people are well-informed about health"], "condition0": ["if there's low public health awareness", "when people are less informed about health matters"], "condition1": ["if there's high public health awareness", "when people are well-informed about health matters"], "action0": ["public health awareness decreases", "people become less informed about health issues"], "action1": ["public health awareness increases", "people become more informed about health issues"]}}, "queries": [{"treatment": "Patent Waiver Implementation", "query": "ate", "type": "ate-sign", "criterion": "<"}, {"treatment": "Global Health Policy Support", "query": "ate", "type": "ate-sign", "criterion": ">"}, {"treatment1": "Global Health Policy Support", "treatment2": "Patent Waiver Implementation", "query": "ate", "type": "ate-compare", "criterion": "<"}, {"treatment1": "Patent Waiver Implementation", "treatment2": "Global Health Policy Support", "query": "ate", "type": "ate-compare-mag", "criterion": "<"}, {"treatment": "Patent Waiver Implementation", "confounder": "Economic Status of Countries", "confounder_value": 0, "query": "cate", "type": "cate-sign", "criterion": ">"}, {"treatment": "Global Health Policy Support", "confounder": "Economic Status of Countries", "confounder_value": 0, "query": "cate", "type": "cate-sign", "criterion": ">"}, {"treatment1": "Global Health Policy Support", "treatment2": "Patent Waiver Implementation", "confounder": "Economic Status of Countries", "confounder_value": 0, "query": "cate", "type": "cate-compare-c", "criterion": ">"}, {"treatment1": "Patent Waiver Implementation", "treatment2": "Global Health Policy Support", "confounder": "Economic Status of Countries", "confounder_value": 0, "query": "cate", "type": "cate-compare-c-mag", "criterion": "<"}, {"treatment": "Patent Waiver Implementation", "confounder": "Economic Status of Countries", "confounder_value": 1, "query": "cate", "type": "cate-sign", "criterion": ">"}, {"treatment": "Global Health Policy Support", "confounder": "Economic Status of Countries", "confounder_value": 1, "query": "cate", "type": "cate-sign", "criterion": "<"}, {"treatment1": "Global Health Policy Support", "treatment2": "Patent Waiver Implementation", "confounder": "Economic Status of Countries", "confounder_value": 1, "query": "cate", "type": "cate-compare-c", "criterion": ">"}, {"treatment1": "Patent Waiver Implementation", "treatment2": "Global Health Policy Support", "confounder": "Economic Status of Countries", "confounder_value": 1, "query": "cate", "type": "cate-compare-c-mag", "criterion": ">"}, {"treatment": "Patent Waiver Implementation", "confounder": "Economic Status of Countries", "confounder_order": [1, 0], "query": "cate", "type": "cate-compare-t", "criterion": ">"}, {"treatment": "Patent Waiver Implementation", "confounder": "Economic Status of Countries", "confounder_order": [1, 0], "query": "cate", "type": "cate-compare-t-mag", "criterion": "<"}, {"treatment": "Global Health Policy Support", "confounder": "Economic Status of Countries", "confounder_order": [1, 0], "query": "cate", "type": "cate-compare-t", "criterion": ">"}, {"treatment": "Global Health Policy Support", "confounder": "Economic Status of Countries", "confounder_order": [1, 0], "query": "cate", "type": "cate-compare-t-mag", "criterion": "<"}, {"treatment": "Patent Waiver Implementation", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 0, "query": "cate", "type": "cate-sign", "criterion": ">"}, {"treatment": "Global Health Policy Support", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 0, "query": "cate", "type": "cate-sign", "criterion": "<"}, {"treatment1": "Patent Waiver Implementation", "treatment2": "Global Health Policy Support", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 0, "query": "cate", "type": "cate-compare-c", "criterion": ">"}, {"treatment1": "Patent Waiver Implementation", "treatment2": "Global Health Policy Support", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 0, "query": "cate", "type": "cate-compare-c-mag", "criterion": ">"}, {"treatment": "Patent Waiver Implementation", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 1, "query": "cate", "type": "cate-sign", "criterion": ">"}, {"treatment": "Global Health Policy Support", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 1, "query": "cate", "type": "cate-sign", "criterion": ">"}, {"treatment1": "Global Health Policy Support", "treatment2": "Patent Waiver Implementation", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 1, "query": "cate", "type": "cate-compare-c", "criterion": "<"}, {"treatment1": "Patent Waiver Implementation", "treatment2": "Global Health Policy Support", "confounder": "Pharmaceutical Industry Influence", "confounder_value": 1, "query": "cate", "type": "cate-compare-c-mag", "criterion": "<"}, {"treatment": "Patent Waiver Implementation", "confounder": "Pharmaceutical Industry Influence", "confounder_order": [1, 0], "query": "cate", "type": "cate-compare-t", "criterion": ">"}, {"treatment": "Patent Waiver Implementation", "confounder": "Pharmaceutical Industry Influence", "confounder_order": [0, 1], "query": "cate", "type": "cate-compare-t-mag", "criterion": "<"}, {"treatment": "Global Health Policy Support", "confounder": "Pharmaceutical Industry Influence", "confounder_order": [1, 0], "query": "cate", "type": "cate-compare-t", "criterion": ">"}, {"treatment": "Global Health Policy Support", "confounder": "Pharmaceutical Industry Influence", "confounder_order": [0, 1], "query": "cate", "type": "cate-compare-t-mag", "criterion": "<"}], "questions": [{"question": "Does the implementation of patent waivers for vaccines negatively affect global vaccine availability?", "answer": "yes", "claim": "Implementing patent waivers for vaccines leads to a decrease in global vaccine availability."}, {"question": "Does supporting global health policies positively influence vaccine distribution internationally?", "answer": "yes", "claim": "Supporting global health policies improves the efficiency of international vaccine distribution."}, {"question": "Is the impact of supporting global health policies less than the impact of implementing patent waivers on vaccine availability?", "answer": "yes", "claim": "The effect of implementing patent waivers on vaccine availability is greater than that of supporting global health policies."}, {"question": "Is the absolute impact of implementing patent waivers smaller than the absolute impact of supporting global health policies on vaccine distribution?", "answer": "yes", "claim": "The overall influence of supporting global health policies on vaccine distribution is greater than that of implementing patent waivers."}, {"question": "In countries with low economic status, does implementing patent waivers improve vaccine availability?", "answer": "yes", "claim": "In economically struggling countries, implementing patent waivers leads to better vaccine availability."}, {"question": "In countries with low economic status, does supporting global health policies improve vaccine distribution?", "answer": "yes", "claim": "In economically struggling countries, supporting global health policies enhances vaccine distribution."}, {"question": "In countries with low economic status, is the impact of supporting global health policies greater than the impact of implementing patent waivers on vaccine availability?", "answer": "yes", "claim": "For countries with weaker economies, the positive effect of supporting global health policies on vaccine availability surpasses that of implementing patent waivers."}, {"question": "In countries with low economic status, is the absolute impact of implementing patent waivers smaller than the absolute impact of supporting global health policies on vaccine distribution?", "answer": "yes", "claim": "In economically weaker countries, the overall influence of supporting global health policies on vaccine distribution is greater than that of implementing patent waivers."}, {"question": "In countries with high economic status, does implementing patent waivers improve vaccine availability?", "answer": "yes", "claim": "In economically stable countries, implementing patent waivers leads to better vaccine availability."}, {"question": "In countries with high economic status, does supporting global health policies negatively affect vaccine distribution?", "answer": "yes", "claim": "In economically strong countries, supporting global health policies does not improve vaccine distribution."}, {"question": "In countries with high economic status, is the impact of supporting global health policies greater than the impact of implementing patent waivers on vaccine availability?", "answer": "yes", "claim": "For countries with strong economies, the positive effect of supporting global health policies on vaccine availability is greater than that of implementing patent waivers."}, {"question": "In countries with high economic status, is the absolute impact of implementing patent waivers greater than the absolute impact of supporting global health policies on vaccine distribution?", "answer": "yes", "claim": "In economically strong countries, the overall influence of implementing patent waivers on vaccine availability is greater than that of supporting global health policies."}, {"question": "Is the improvement in vaccine availability due to patent waivers greater in countries with high economic status compared to those with low economic status?", "answer": "yes", "claim": "Countries with higher economic status see a greater improvement in vaccine availability from implementing patent waivers compared to economically struggling countries."}, {"question": "Is the absolute improvement in vaccine availability due to patent waivers smaller in countries with high economic status compared to those with low economic status?", "answer": "yes", "claim": "The absolute benefit of implementing patent waivers on vaccine availability is less in economically strong countries compared to economically struggling ones."}, {"question": "Is the improvement in vaccine distribution due to supporting global health policies greater in countries with high economic status compared to those with low economic status?", "answer": "yes", "claim": "Countries with higher economic status see a greater improvement in vaccine distribution from supporting global health policies compared to economically struggling countries."}, {"question": "Is the absolute improvement in vaccine distribution due to supporting global health policies smaller in countries with high economic status compared to those with low economic status?", "answer": "yes", "claim": "The absolute benefit of supporting global health policies on vaccine distribution is less in economically strong countries compared to economically struggling ones."}, {"question": "With low pharmaceutical industry influence, does implementing patent waivers improve vaccine availability?", "answer": "yes", "claim": "When the pharmaceutical industry has minimal influence, implementing patent waivers leads to better vaccine availability."}, {"question": "With low pharmaceutical industry influence, does supporting global health policies negatively affect vaccine distribution?", "answer": "yes", "claim": "When the pharmaceutical industry has minimal influence, supporting global health policies does not improve vaccine distribution."}, {"question": "With low pharmaceutical industry influence, is the impact of implementing patent waivers greater than the impact of supporting global health policies on vaccine availability?", "answer": "yes", "claim": "When the pharmaceutical industry has low influence, the positive effect of implementing patent waivers on vaccine availability is greater than that of supporting global health policies."}, {"question": "With low pharmaceutical industry influence, is the absolute impact of implementing patent waivers greater than the absolute impact of supporting global health policies on vaccine distribution?", "answer": "yes", "claim": "In the context of low pharmaceutical industry influence, the overall influence of implementing patent waivers on vaccine availability is greater than that of supporting global health policies."}, {"question": "With high pharmaceutical industry influence, does implementing patent waivers improve vaccine availability?", "answer": "yes", "claim": "When the pharmaceutical industry has significant influence, implementing patent waivers leads to better vaccine availability."}, {"question": "With high pharmaceutical industry influence, does supporting global health policies improve vaccine distribution?", "answer": "yes", "claim": "When the pharmaceutical industry has significant influence, supporting global health policies enhances vaccine distribution."}, {"question": "With high pharmaceutical industry influence, is the impact of implementing patent waivers greater than the impact of supporting global health policies on vaccine availability?", "answer": "yes", "claim": "When the pharmaceutical industry has high influence, the positive effect of implementing patent waivers on vaccine availability is greater than that of supporting global health policies."}, {"question": "With high pharmaceutical industry influence, is the absolute impact of implementing patent waivers smaller than the absolute impact of supporting global health policies on vaccine distribution?", "answer": "yes", "claim": "In the context of high pharmaceutical industry influence, the overall influence of supporting global health policies on vaccine distribution is greater than that of implementing patent waivers."}, {"question": "Is the improvement in vaccine availability due to patent waivers greater with high pharmaceutical industry influence compared to low influence?", "answer": "yes", "claim": "The improvement in vaccine availability from implementing patent waivers is more pronounced when the pharmaceutical industry has high influence compared to when it has low influence."}, {"question": "Is the absolute improvement in vaccine availability due to patent waivers smaller with low pharmaceutical industry influence compared to high influence?", "answer": "yes", "claim": "The absolute benefit of implementing patent waivers on vaccine availability is less when the pharmaceutical industry has low influence compared to when it has high influence."}, {"question": "Is the improvement in vaccine distribution due to supporting global health policies greater with high pharmaceutical industry influence compared to low influence?", "answer": "yes", "claim": "The improvement in vaccine distribution from supporting global health policies is more pronounced when the pharmaceutical industry has high influence compared to when it has low influence."}, {"question": "Is the absolute improvement in vaccine distribution due to supporting global health policies smaller with low pharmaceutical industry influence compared to high influence?", "answer": "yes", "claim": "The absolute benefit of supporting global health policies on vaccine distribution is less when the pharmaceutical industry has low influence compared to when it has high influence."}]}